Role of immunologic and inflammatory factors in the development of endometriosis: indications for treatment strategies

Attila Mihalyi, Kyama C Mutinda, Péter Simsa, Sophie Debrock, Jason M. Mwenda, Thomas D'Hooghe, Thomas D’Hooghe
In: Therapy · 2005 · vol. 2(4) , pp. 623–639 · doi:10.2217/14750708.2.4.623 · W2140404610
Review OA: closed CC0 ⤵ 22 in-corpus citations
Full text JSON View on OpenAlex View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-06 ⓘ

This review examines immunologic and inflammatory factors contributing to endometriosis, highlighting their potential for developing new treatments that address the condition without hormonal interference.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-10-09 · read from full text ⓘ

The provided text is not a biomedical research paper but rather a marketing brochure for a strategic communications firm specializing in healthcare and life sciences. It outlines the company’s approach to building influence through precision, depth, and access rather than mass visibility. The content describes their business model of positioning clients as conveners and owning relationships, with no mention of scientific data or clinical findings. Relevance to endometriosis: listed as one indication for GnRH antagonists, though the paper's main focus is uterine fibroids.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

This article presents an overview of immunologic/inflammatory factors related to endometriosis with special attention to their potential relevance to future treatment strategies. The development of endometriosis appears to involve several immunologic and inflammatory factors. Increased inflammatory, proteolytic and angiogenic activity of the peritoneum and the peritoneal fluid, and poor immune surveillance and clearance of endometrial cells from the pelvic cavity all appear to contribute to the development of endometriosis. The presently available pharmacotherapeutic treatments are characterized by high recurrence rates, severe side effects and limited duration of application. These and the consequences of endometriosis on the quality of life of affected women, their environment and the society, clearly indicate the need for the development of new drugs, abolishing endometriosis and its symptoms, without interfering with the hormonal homeostasis. Substances potentially capable of modulating immunologic/in...
Full text 726 characters · extracted from oa-doi-fallback · click to expand
Others sell reach. We build influence. Strategic communications and narrative advisory for healthcare and life sciences - through the conversations you host and the rooms we convene. The people who shape your market can't be reached by volume. We work with the few who decide - through precision, depth, and access. How we're different 01 We optimise for understated influence, proximity and positioning, not mass visibility or amplification. 02 We position our clients as the convener, not the vendor - the one who frames the conversation, not another voice competing for attention within it. 03 We build things our clients own outright - the show, the room, the relationships - not moments rented on someone else's platform.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (100)

Cited by (22)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-10-20T06:27:24.728081+00:00
License: CC0 · commercial use OK